For decades, Excel has been the default tool for planning. It is flexible, familiar, and deeply embedded in how organizations operate. For many teams, it has been “good enough”, a reliable way to bridge gaps between systems, model scenarios, and manage day-to-day planning activities.
But “good enough” is no longer good enough.
In most industries, supply chain disruptions are measured in cost and service levels. In medical devices, they are measured in patient outcomes. A delayed shipment is not just a missed delivery, it can mean postponed procedures, compromised care, or limited access to critical therapies.
That reality changes the standard. And it exposes the limitations of tools that were never designed for this level of responsibility.
Medical device supply chains operate under a unique and intensifying set of pressures. Regulatory requirements demand strict traceability across every stage of the product lifecycle, from raw materials through finished goods. Product portfolios continue to expand, often with frequent engineering changes, multiple configurations, and tightly managed lifecycle transitions.
At the same time, demand is not purely statistical. It is shaped by procedure volumes, regional dynamics, and adoption rates. These factors introduce variability that traditional forecasting methods struggle to capture.
Complex supply chains also extend far beyond internal operations. Contract manufacturers, sterilization providers, logistics partners, and field service networks all play critical roles in delivering finished products to patients. Coordination across this ecosystem is essential, yet often fragmented.
Layer on top the complexity of managing capital equipment, consumables, spare parts, and service commitments, each with fundamentally different planning requirements, and it becomes clear that this is not a traditional planning problem.
It is a coordination problem at scale.
Excel was never designed to operate as a system of coordination. It is a powerful tool for analysis, but it functions in isolation.
As complexity increases, so does the number of spreadsheets, assumptions, and manual interventions required to keep plans aligned. Over time, this creates fragmentation. Different teams operate from different data sets. Planning cycles slow as effort shifts from decision-making to reconciliation. Scenario analysis becomes cumbersome, limiting the ability to respond quickly to change.
Most critically, interdependencies are lost. A shift in demand impacts production, which affects supplier requirements, which influences inventory positioning and service levels. In a spreadsheet-driven environment, these relationships are disconnected, making it difficult to understand the full impact of a decision before it is made.
What once provided flexibility ultimately introduces risk.
Many organizations attempt to address these challenges by consolidating planning within their ERP systems. While this can improve data consistency, it does not fundamentally solve the problem.
ERP platforms are built for execution and transaction management. They are not designed for rapid, iterative decision-making or scenario evaluation. They struggle to support the dynamic, cross-functional coordination required in today’s environment.
As a result, organizations often find themselves operating between two constraints: spreadsheets that are flexible but disconnected, and systems that are integrated but rigid.
Neither enables the level of responsiveness now required.
Leading medical device organizations are moving beyond traditional planning models toward something more advanced: adaptive, connected supply chains.
This shift is about more than visibility. It is about enabling concurrent, real-time decision-making across demand, supply, and inventory. It is about ensuring that changes in one area are immediately reflected across the entire network, allowing teams to evaluate trade-offs and respond with confidence.
In this model, inventory is no longer treated as a static buffer to be minimized. It becomes a strategic lever—positioned deliberately across the network to balance service levels, working capital, and risk.
External partners are no longer loosely connected through periodic updates. They are integrated into the planning process, enabling coordination across contract manufacturers, suppliers, and service networks in near real time.
This is the foundation of an adaptive supply chain which can sense disruption, evaluate options, and act quickly while maintaining compliance and control.
The impact of this shift is profound.
Organizations gain the ability to anticipate shortages before they occur, rather than reacting to them after the fact. Product transitions can be managed more effectively, reducing the risk of obsolescence or service disruption. Inventory can be positioned more intelligently, improving service levels without unnecessary excess.
At the same time, teams spend less time managing data and more time making decisions. Alignment across functions improves, enabling faster responses to changing market conditions and operational challenges.
In an industry where reliability and responsiveness are directly tied to patient care, this level of control is not optional, it is essential.
Excel will continue to play a role in the enterprise. It remains a valuable tool for analysis and flexibility at the edges.
But it should no longer serve as the foundation of supply chain planning.
As medical device supply chains continue to grow in complexity, the cost of disconnected planning increases. What was once an operational workaround becomes a strategic constraint.
The organizations that move beyond spreadsheets are not simply improving efficiency. They are building supply chains that are more resilient, more responsive, and better aligned to the realities of their industry.
The question is no longer whether Excel can support planning.
It is whether your supply chain can afford to depend on it.
Article 1: Medical Device Planning Was Never Built for Excel
Article 2: Inventory Strategy in Medical Devices: It’s Not How Much. It’s Where.
Article 3: Why Planning Systems Break in Complex Supply Chains
Article 4: From Reactive to Proactive Planning in a Medical Device Supply Chain
